Coya Therapeutics Income Statement (2022-2025) | COYA

Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 6.00M0.13M3.43M0.00M0.26M0.16M3.56M
Operating items
Depreciation & Amortization - Total 0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Research & Development 1.23M1.07M1.59M1.61M3.14M4.57M2.22M1.94M5.21M3.66M2.92M
Selling, General & Administrative 1.66M1.83M1.96M2.38M2.44M2.09M2.22M2.14M2.71M2.91M2.56M
Restructuring Costs 1.50M1.05M1.08M0.99M1.33M1.55M1.18M
Other Operating Expenses 0.35M0.19M-1.47M-1.05M-1.08M-0.99M-1.33M-1.55M-0.67M
Operating Expenses 2.90M3.25M3.56M4.19M5.61M6.66M4.45M4.08M7.93M6.58M6.00M
Operating Income -2.90M-3.25M-3.56M1.82M-5.48M-3.24M-4.45M-4.08M-7.68M-6.41M-2.43M
EBIT -2.90M-3.25M-3.56M1.82M-5.48M-3.24M-4.45M-4.08M-7.68M-6.41M-2.43M
Non-operating items
Other Non Operating Income 0.16M0.16M0.14M0.17M0.43M0.34M0.43M0.44M0.37M0.32M0.32M
Non Operating Income 0.16M0.16M0.14M0.17M0.43M0.34M0.43M0.44M0.37M0.32M0.32M
Net income details
EBT -2.90M-3.25M-3.56M1.82M-5.05M-2.89M-4.45M-4.08M-7.31M-6.09M-2.43M
Profit After Tax -2.74M-3.10M-3.42M1.27M-5.05M-2.89M-4.02M-2.92M-7.31M-6.09M-2.12M
Income from Continuing Operations -2.90M-3.25M-3.56M1.82M-5.05M-2.89M-4.45M-4.08M-7.31M-6.09M-2.43M
Consolidated Net Income -2.90M-3.25M-3.56M1.82M-5.05M-2.89M-4.45M-4.08M-7.31M-6.09M-2.43M
Income towards Parent Company -2.90M-3.25M-3.56M1.82M-5.05M-2.89M-4.45M-4.08M-7.31M-6.09M-2.43M
Net Income towards Common Stockholders -2.90M-3.25M-3.56M1.82M-5.05M-2.89M-4.45M-4.08M-7.31M-6.09M-2.43M
Additional items
EPS (Basic) -0.28-0.31-0.340.15-0.35-0.19-0.26-0.27-0.44-0.36-0.13
EPS (Weighted Average and Diluted) -0.28-0.31-0.340.15-0.35-0.19-0.26-0.27-0.44-0.36-0.13
Shares Outstanding (Weighted Average) 2.59M2.59M2.59M2.59M9.72M9.95M9.95M10.16M14.46M14.92M15.22M15.24M16.72M16.72M16.73M
Shares Outstanding (Diluted Average) 2.59M2.59M2.59M2.59M9.72M9.95M9.95M10.16M14.46M14.92M15.22M15.24M16.72M16.72M16.73M
EBITDA -2.89M-3.25M-3.56M1.82M-5.48M-3.23M-4.44M-4.07M-7.67M-6.41M-2.43M